SOURCE: Leerink Swann & Company

May 24, 2005 08:39 ET

Leerink Swann & Company Initiates Coverage of Luminex Corporation (NASDAQ: LMNX)

BOSTON, MA -- (MARKET WIRE) -- May 24, 2005 -- This morning, Senior Biotechnology Analyst John Sullivan initiated coverage of Luminex Corporation with an Outperform rating.

About Luminex Corporation

Luminex Corporation (NASDAQ: LMNX) develops, manufactures and markets innovative biological testing technologies with applications throughout the life-sciences industry. The company is headquartered in Austin, Texas.

About Leerink Swann & Company

Leerink Swann & Company is an investment banking firm that provides healthcare equity research, corporate finance, and asset management services for institutional and high-net-worth clients. Leerink Swann & Company was voted the Best Firm in Biotechnology, Medical Supplies and Devices, Pharmaceuticals/Major and Pharmaceuticals/Specialty in the December 2004 Institutional Investor poll ranking the best boutique and regional firms by sector. Through its consulting affiliate, MEDACorp, Leerink Swann & Company provides biomedical-consulting services to Life Sciences companies and to the institutional investment community. MEDACorp includes thousands of biomedical professionals and practicing physicians. Leerink Swann & Company is a member NASD/SIPC.

Contact Information

  • Contact:
    John I. Fitzgerald
    Leerink Swann & Company
    (617) 918-4564
    www.leerink.com